IL2 and Sepsis: Notably, while immature myeloid cell numbers remain elevated for ≥ 6 weeks post-sepsis onset, only MDSCs acquired after the 2-week post-onset window exhibit potent inhibition of T lymphocyte proliferation and IL-2 synthesis, suggesting their pivotal role in maintaining chronic immunosuppression during the late phase of sepsis (60).